Clostridium difficile
Showing 1 - 25 of 2,514
Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection Trial in Worcester (Fecal Microbiota
Recruiting
- Clostridium Difficile Infection Recurrence
- Clostridium Difficile Infection
- Fecal Microbiota Transplantation
-
Worcester, MassachusettsUMass Memorial Medical Center
Dec 19, 2022
Clostridium Difficile Infections Trial (Fecal microbiota transplant (Promicrobioma), Antibiotic)
Not yet recruiting
- Clostridium Difficile Infections
- Fecal microbiota transplant (Promicrobioma)
- Antibiotic
- (no location specified)
Oct 27, 2023
Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)
Completed
- Clostridium Infection
- Collection of peripheral blood mononuclear cells
-
Paris, FranceMaladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
Oct 3, 2022
Clostridioides Difficile Infection: Analyzing CLInic Evolution
Not yet recruiting
- Clostridium Difficile Infections
-
Paris, FranceFondation Hôpital Saint-Joseph
Sep 11, 2023
Clostridium Difficile Infection Trial (CB-183,315, Vancomycin, Placebo)
Clostridioides Difficile Infection, Clostridium Difficile Infection, Clostridium Difficile Diarrhea Trial in Charlottesville
Recruiting
- Clostridioides Difficile Infection
- +3 more
-
Charlottesville, VirginiaUVA Health Systems
Nov 2, 2022
Clostridium Difficile Infection, Diarrhea Trial (kefir)
Terminated
- Clostridium Difficile Infection
- Diarrhea
- (no location specified)
May 17, 2022
Clostridium Difficile Colonization, Clostridium Difficile Diarrhea Trial in Hamilton (Vancomycin, Culturelle, Vancomycin
Not yet recruiting
- Clostridium Difficile Colonization
- Clostridium Difficile Diarrhea
- Vancomycin
- +3 more
-
Hamilton, Ontario, Canada
- +1 more
Aug 4, 2022
Bezlotoxumab for Management of Clostridioides Difficile
Enrolling by invitation
- Clostridium Difficile Infection
- Clostridium Difficile Infection Recurrence
- Bezlotoxumab
- Standard CDI treatment
-
Maywood, IllinoisLoyola University Medical Center
Nov 1, 2022
REBYOTA™ Prospective Registry
Not yet recruiting
- Recurrence of Clostridium Difficile Infection
- (no location specified)
Apr 18, 2023
Clostridium Difficile Infection, Fecal Microbiota Transplantation Trial in Shanghai (Fecal microbiota transplantation)
Completed
- Clostridium Difficile Infection
- Fecal Microbiota Transplantation
- Fecal microbiota transplantation
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Jan 27, 2023
IBD, Ulcerative Colitis, Crohn Disease Trial in Pittsburgh (Bezlotoxumab)
Recruiting
- Inflammatory Bowel Diseases
- +3 more
- Bezlotoxumab
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Sep 13, 2022
Clostridium Difficile Trial in St. John's (Fecal Microbiota Transplantation, Vancomycin, Fecal Microbiota Transplantation
Withdrawn
- Clostridium Difficile
- Fecal Microbiota Transplantation
- +3 more
-
St. John's, Newfoundland and Labrador, CanadaHealth Sciences Centre
Apr 22, 2022
IBD, Clostridium Difficile Infections, Microtia Trial in Shanghai (Clostridioides difficile toxin detection)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- Clostridioides difficile toxin detection
-
Shanghai, Shanghai, ChinaShanghai jiaotong university, school of medicine, affliated Renj
Feb 3, 2023
IBD, Clostridium Difficile Infection Trial in Boston (Bezlotoxumab, Placebo, Fecal Microbiota Transplantation)
Recruiting
- Inflammatory Bowel Diseases
- Clostridium Difficile Infection
- Bezlotoxumab
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 5, 2023
Clostridium Difficile Trial in Chapel Hill (Stool specimen)
Completed
- Clostridium Difficile
- Stool specimen
-
Chapel Hill, North CarolinaUNC Chapel Hill
Mar 25, 2022
Clostridium Difficile Trial in Bronx (Bezlotoxumab)
Terminated
- Clostridium Difficile
-
Bronx, New YorkMontefiore Medical Center
Oct 13, 2022
Antimicrobial Stewardship Program for Clostridium Difficile
Completed
- Clostridium Difficile
- Enterocolitis, Pseudomembranous
- Systematic evaluation by an ID expert.
-
Madrid, SpainUnidad de Enfermedades Infecciosas. Hospital Universitario 12 de
Mar 30, 2022
Clostridium Difficile Infection Recurrence Trial in North Little Rock, Shreveport (RBX2660)
Recruiting
- Clostridium Difficile Infection Recurrence
-
North Little Rock, Arkansas
- +1 more
Apr 27, 2023
Clostridium Difficile Associated Disease Trial in United States (Clostridium difficile vaccine, )
Completed
- Clostridium Difficile Associated Disease
- Clostridium difficile vaccine
- placebo
-
Mobile, Alabama
- +23 more
Dec 21, 2022
Recurrent Clostridium Difficile Infection, Fecal Microbiota Transplant Trial in Minneapolis (MEND diet, mNICE diet)
Not yet recruiting
- Recurrent Clostridium Difficile Infection
- Fecal Microbiota Transplant
- MEND diet
- mNICE diet
-
Minneapolis, MinnesotaUniversity of Minnesota
Apr 20, 2023
Clostridium Difficile Infection, Clostridioides Difficile Infection Trial in Aarhus N (Fecal microbiota transplantion (FMT),
Active, not recruiting
- Clostridium Difficile Infection
- Clostridioides Difficile Infection
- Fecal microbiota transplantion (FMT)
- Placebo
-
Aarhus N, DenmarkAarhus University Hospital
Jun 7, 2022
Immune Response to C.Difficile Infection
Recruiting
- Clostridium Difficile
-
Charlottesville, VirginiaUniversity of Virginia Health System
May 31, 2022
Allogeneic Hematopoietic Stem Cell Trial in New York (fecal microbiota transplantation (FMT), No fecal microbiota
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell
- fecal microbiota transplantation (FMT)
- No fecal microbiota transplantation (FMT), routine management
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 25, 2022
Active C. Difficile Colitis Trial in Houston (Microbiota Transplantation (FMT))
Enrolling by invitation
- Active C. Difficile Colitis
- Microbiota Transplantation (FMT)
-
Houston, TexasMichael E DeBakey Veterans Affairs Medical Center
Feb 24, 2022